What is it about?
B-cell lymphoproliferative disorders encompass a diverse range of neoplasms with immunophenotypic profiles. This review discusses the classification of BCLPDs based on flow cytometric immunophenotyping, focusing on markers such as CD5, and CD10.
Featured Image
Why is it important?
Advanced flow cytometry techniques aid in subtype differentiation, guiding personalized treatment approaches and improving outcomes. Global variations and diagnostic challenges are also highlighted, supporting a comprehensive understanding of BCLPDs.
Perspectives
This review discusses the classification of BCLPDs based on flow cytometric immunophenotyping, focusing on markers such as CD5, and CD10. Key subtypes, including CLL, MCL, and DLBCL, are analyzed for diagnostic and prognostic insights.
Thushara Balasuriya
Read the Original
This page is a summary of: Overview of Flow Cytometry Techniques for Immunophenotyping in B-Cell Lymphoproliferative Disorders, December 2024, Sciencedomain International,
DOI: 10.9734/bpi/acmms/v7/3477.
You can read the full text:
Contributors
The following have contributed to this page
